Unlocking new horizons: advances in treating IDH-mutant, 1p/19q-codeleted oligodendrogliomas
Abstract Oligodendrogliomas are a distinct subtype of diffuse gliomas characterized by IDH mutations and 1p/19q codeletion, classified as grade 2 or 3 based on histological features. This review examines current advancements in the diagnosis, treatment, and prognosis of oligodendrogliomas, with an e...
Saved in:
| Main Authors: | Jing Bao, Zhenjiang Pan, Shepeng Wei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-05-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02815-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vorasidenib for IDH-mutant grade 2 gliomas: clinical advances and future directions
by: Zhenjiang Pan, et al.
Published: (2025-06-01) -
Multipool-CEST and CEST-based pH assessment as predictive tools for glioma grading, IDH mutation, 1p/19q codeletion, and MGMT promoter methylation in gliomas
by: Xinli Zhang, et al.
Published: (2024-12-01) -
Frequency and Prognostic Impact of CDKN2A/B Alteration in Oligodendrogliomas: Systematic Review and Meta-analysis
by: Satoshi NAKASU, et al.
Published: (2024-12-01) -
A dual-genotype IDH-mutant infiltrating glioma, a real oligoastrocytoma in cerebral hemisphere
by: Jing Liu, PhD, et al.
Published: (2025-06-01) -
Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma
by: Alexander S. Himstead, et al.
Published: (2025-01-01)